Antibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [3]
- Immunoprecipitation [1]
- Immunohistochemistry [3]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN151288 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Matrin 3 (MATR3) (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human, Mouse, Xenopus
- Host
- Rabbit
- Epitope
- C-Term
- Vial size
- 0.1 mL
- Storage
- Store at 4°C. Do not freeze.
- Handling
- Do not freeze.
Submitted references Matrin 3 variants are frequent in Italian ALS patients.
Heterogeneity of Matrin 3 in the developing and aging murine central nervous system.
Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype.
TRAP150 interacts with the RNA-binding domain of PSF and antagonizes splicing of numerous PSF-target genes in T cells.
The Zinc-Finger Antiviral Protein ZAP Inhibits LINE and Alu Retrotransposition.
Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations.
A novel nuclear FGF Receptor-1 partnership with retinoid and Nur receptors during developmental gene programming of embryonic stem cells.
Matrin 3 binds and stabilizes mRNA.
The alphaherpesvirus US3/ORF66 protein kinases direct phosphorylation of the nuclear matrix protein matrin 3.
Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy.
Marangi G, Lattante S, Doronzio PN, Conte A, Tasca G, Monforte M, Patanella AK, Bisogni G, Meleo E, La Spada S, Zollino M, Sabatelli M
Neurobiology of aging 2017 Jan;49:218.e1-218.e7
Neurobiology of aging 2017 Jan;49:218.e1-218.e7
Heterogeneity of Matrin 3 in the developing and aging murine central nervous system.
Rayaprolu S, D'Alton S, Crosby K, Moloney C, Howard J, Duffy C, Cabrera M, Siemienski Z, Hernandez AR, Gallego-Iradi C, Borchelt DR, Lewis J
The Journal of comparative neurology 2016 Oct 1;524(14):2740-52
The Journal of comparative neurology 2016 Oct 1;524(14):2740-52
Transgenic mice overexpressing the ALS-linked protein Matrin 3 develop a profound muscle phenotype.
Moloney C, Rayaprolu S, Howard J, Fromholt S, Brown H, Collins M, Cabrera M, Duffy C, Siemienski Z, Miller D, Swanson MS, Notterpek L, Borchelt DR, Lewis J
Acta neuropathologica communications 2016 Nov 18;4(1):122
Acta neuropathologica communications 2016 Nov 18;4(1):122
TRAP150 interacts with the RNA-binding domain of PSF and antagonizes splicing of numerous PSF-target genes in T cells.
Yarosh CA, Tapescu I, Thompson MG, Qiu J, Mallory MJ, Fu XD, Lynch KW
Nucleic acids research 2015 Oct 15;43(18):9006-16
Nucleic acids research 2015 Oct 15;43(18):9006-16
The Zinc-Finger Antiviral Protein ZAP Inhibits LINE and Alu Retrotransposition.
Moldovan JB, Moran JV
PLoS genetics 2015 May;11(5):e1005121
PLoS genetics 2015 May;11(5):e1005121
Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations.
Depreux FF, Puckelwartz MJ, Augustynowicz A, Wolfgeher D, Labno CM, Pierre-Louis D, Cicka D, Kron SJ, Holaska J, McNally EM
Human molecular genetics 2015 Aug 1;24(15):4284-95
Human molecular genetics 2015 Aug 1;24(15):4284-95
A novel nuclear FGF Receptor-1 partnership with retinoid and Nur receptors during developmental gene programming of embryonic stem cells.
Lee YW, Terranova C, Birkaya B, Narla S, Kehoe D, Parikh A, Dong S, Ratzka A, Brinkmann H, Aletta JM, Tzanakakis ES, Stachowiak EK, Claus P, Stachowiak MK
Journal of cellular biochemistry 2012 Sep;113(9):2920-36
Journal of cellular biochemistry 2012 Sep;113(9):2920-36
Matrin 3 binds and stabilizes mRNA.
Salton M, Elkon R, Borodina T, Davydov A, Yaspo ML, Halperin E, Shiloh Y
PloS one 2011;6(8):e23882
PloS one 2011;6(8):e23882
The alphaherpesvirus US3/ORF66 protein kinases direct phosphorylation of the nuclear matrix protein matrin 3.
Erazo A, Yee MB, Banfield BW, Kinchington PR
Journal of virology 2011 Jan;85(1):568-81
Journal of virology 2011 Jan;85(1):568-81
Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy.
Schessl J, Zou Y, McGrath MJ, Cowling BS, Maiti B, Chin SS, Sewry C, Battini R, Hu Y, Cottle DL, Rosenblatt M, Spruce L, Ganguly A, Kirschner J, Judkins AR, Golden JA, Goebel HH, Muntoni F, Flanigan KM, Mitchell CA, Bönnemann CG
The Journal of clinical investigation 2008 Mar;118(3):904-12
The Journal of clinical investigation 2008 Mar;118(3):904-12
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ICC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ICC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ICC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IP
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC